Meridiem Capital Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Meridiem Capital Partners's CDNA Position: Q2 2026 in Review
Meridiem Capital Partners increased its CareDx (CDNA) stake by 42% in Q2 2026, buying an estimated $2.93M and bringing the position to 451,493 shares worth $12.9M. The position accounts for 0.58% of the portfolio, ranked #66.
Meridiem Capital Partners first reported a position in CDNA in Q2 2025 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Meridiem Capital Partners held 451,493 shares of CareDx worth $12.9M as of Q2 2026.
- Meridiem Capital Partners bought 134,543 CareDx shares in Q2 2026, an estimated $2.93M.
- CareDx made up 0.58% of Meridiem Capital Partners's portfolio in Q2 2026, its #66 holding.
- Meridiem Capital Partners first reported a position in CareDx in Q2 2025 and has held it in 3 quarters since.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.